Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patients

Clinical Kidney Journal

Volumn 6, Issue 4, 2013, Pages 402-409

  Wolley, Martin ^a   Stewart, Ralph ^a   Curry, Elizabeth ^a   Davidson, James ^a   White, Harvey ^a   Pilmore, Helen ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

cardiovascular risk; end stage renal failure; haemodialysis; high sensitivity troponin T

Indexed keywords

TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH SENSTIVITY TROPONIN T ASSAY; HUMAN; IMMUNOASSAY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

EID: 84881447198     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs122     Document Type: Article

References (38)

1. Reichlin T, Hochholzer W, Bassetti S et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361:858-867
2. Keller T, Zeller T, Peetz D et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-877
3. White HD. Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made? Am Heart J 2010;159:933-936
4. Roberts MA, Polkinghorne KR, McDonald SP et al. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis 2011;58:64-72
5. Hickman PE. Biomarkers and cardiac disease in patients with end-stage renal disease on dialysis. Clin Biochem Rev 2011;32:115-119
6. Iliou MC, Fumeron C, Benoit MO et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: pchronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001;16:1452-1458
7. Apple FS, Murakami MM, Pearce LA et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-2945
8. Kumar N, Michelis MF, DeVita MV et al. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant 2011;26:665-670
9. Thygesen K, Mair J, Katus H et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-2204
10. Wu AH, Jaffe AS, Apple FS et al. National Academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponinand B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086-2096
11. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-2195
12. Giannitsis E, Kurz K, Hallermayer K et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-261
13. Reichlin T, Irfan A, Twerenbold R et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-145
14. Frankenstein L, Wu AH, Hallermayer K et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068-1071
15. Vasile VC, Saenger AK, Kroning JM et al. Biologic variation of a novel cardiac troponinI assay. Clin Chem 2011; 57:1080-1081
16. Vasile VC, Saenger AK, Kroning JM et al. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-1090
17. Wu AH, Lu QA, Todd J et al. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-58
18. Mongeon FP, Dorais M, Lorier JL et al. Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year. Open Cardiovasc Med J 2009;3:69-77
19. Jacobs LH, van de Kerkhof J, Mingles AM et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009;46(Pt 4):283-290
20. Conway B, McLaughlin M, Sharpe P et al. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant 2005;20:2759-2764
21. Lippi G, Tessitore N, Montagnana M et al. Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med 2008;132:72-76
22. Ahrenholz PG, Winkler RE, Michelsen A et al. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/ albumin relationship. Clin Nephrol 2004;62:21-28
23. Wu AH. Cardiac troponin: friend of the cardiac physician foe to the cardiac patient? Circulation 2006;114:1673-1675
24. Santoro A, Canova C, Mancini E et al. Protein loss in on-line hemofiltration. Blood Purif 2004;22:261-268
25. Ooi DS, Zimmerman D, Graham J et al. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 2001;47:412-441
26. Masson S, Anand I, Favero C et al. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from two large randomized clinical trials. Circulation 2011;125:280-288
27. Khan NA, Hemmelgarn BR, Tonelli M et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088-3096
28. de Filippi C, Wasserman S, Rosanio S et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-359
29. de Flippi CR, de Lemos JA, Christenson RH et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-2502
30. de Lemos JA, Drazner MH, Omland T et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;124:136-145
31. Everett BM, Cook NR, Magnone MC et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011;123:2811-2818
32. Rubin J, Matsushita K, Ballantyne CM et al. Chronic hyperglycemia and subclinical myocardial injury. JACC 2012; 59:484-489
33. Cuevas X, Garcia F, Martin-Malo A et al. Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER study. Blood Purif 2011;33:21-29
34. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148
35. Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol 2005;25:358-362
36. Sharma R, Gaze DC, Pellerin D et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006; 92:804-809
37. McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease-a new aspect of cardiovascular disease. Blood Purif 2010;29:105-110
38. de Filippi CR, Thorn EM, Aggarwal M et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007;100:885-889